← Leaderboards
Alan C Moses
Beth Israel Deaconess Medical Center
$0
Attributed
$0
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 5
By mechanism
M01$0 · 5
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Barbara B Kahn$32,891,170
- Joel K Elmquist$39,930,443
- Robert E Gerszten$34,860,502
- Shingo Kajimura$19,793,785
- Young-Bum Kim$17,058,086
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectInsulinClinical ResearchHuman Therapy EvaluationInsulin Sensitivity /ResistanceInsulinlike Growth FactorHormone Regulation /Control MechanismDrug Screening /EvaluationHormone TherapyDiabetes MellitusRecombinant ProteinsAndrogensTroglitazoneBlood LipidBody CompositionClinical Trial Phase IDiabetes Mellitus TherapyDrug Administration RoutesGlucose ToleranceInhalation Drug AdministrationInjection /InfusionInsulin Dependent Diabetes Mellitus
Grant awards (25)
INSULIN &INSULIN LIKE GROWTH FACTOR 1--INSULIN RESISTAN$0
M01 · FY2002 · RR
INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES$0
M01 · FY2002 · RR
INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM$0
M01 · FY2002 · RR
CHARACTERIZATION OF INSULIN &INSULIN LIKE GROWTH FACTOR RESPONSES$0
M01 · FY2002 · RR
TROGLITAZONE IN MODERATE TO SEVERE INSULIN RESISTANCE$0
M01 · FY2002 · RR
INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES$0
M01 · FY2001 · RR
INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM$0
M01 · FY2001 · RR
CHARACTERIZATION OF INSULIN &INSULIN LIKE GROWTH FACTOR RESPONSES$0
M01 · FY2001 · RR
TROGLITAZONE IN MODERATE TO SEVERE INSULIN RESISTANCE$0
M01 · FY2001 · RR
INSULIN &INSULIN LIKE GROWTH FACTOR 1--INSULIN RESISTAN$0
M01 · FY2001 · RR
TROGLITAZONE IN MODERATE TO SEVERE INSULIN RESISTANCE$0
M01 · FY2000 · RR
TROGLITAZONE IN MODERATE TO SEVERE INSULIN RESISTANCE$0
M01 · FY2000 · RR
INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES$0
M01 · FY2000 · RR
INSULIN &INSULIN LIKE GROWTH FACTOR 1--INSULIN RESISTAN$0
M01 · FY2000 · RR
INSULIN &INSULIN LIKE GROWTH FACTOR 1--INSULIN RESISTAN$0
M01 · FY2000 · RR
INSULIN &INSULIN LIKE GROWTH FACTOR 1--INSULIN RESISTAN$0
M01 · FY2000 · RR
INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES$0
M01 · FY2000 · RR
INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES$0
M01 · FY2000 · RR
INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM$0
M01 · FY2000 · RR
INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM$0
M01 · FY2000 · RR
INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM$0
M01 · FY2000 · RR
CHARACTERIZATION OF INSULIN &INSULIN LIKE GROWTH FACTOR RESPONSES$0
M01 · FY2000 · RR
CHARACTERIZATION OF INSULIN &INSULIN LIKE GROWTH FACTOR RESPONSES$0
M01 · FY2000 · RR
CHARACTERIZATION OF INSULIN &INSULIN LIKE GROWTH FACTOR RESPONSES$0
M01 · FY2000 · RR
TROGLITAZONE IN MODERATE TO SEVERE INSULIN RESISTANCE$0
M01 · FY2000 · RR